Tenon Medical Inc (TNON) — Research Summary as of August 12, 2026

Company Overview

Tenon Medical (NASDAQ: TNON) is a medical device company focused on transforming care for patients with sacro-pelvic disorders [2]. Founded in 2012, the company develops implants for patients with SI-joint dysfunction, a source of chronic lower-back pain. Its flagship product, the Catamaran SI Joint Fusion System, was originally FDA-cleared in 2018 and launched nationally in October 2022, using a single titanium implant delivered through a less invasive posterior-inferior approach [14].